Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000241654 | SCV000310531 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV001106232 | SCV001263277 | benign | Focal segmental glomerulosclerosis 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Athena Diagnostics | RCV000241654 | SCV001475713 | benign | not specified | 2019-12-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001459545 | SCV001663388 | likely benign | not provided | 2023-08-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001106232 | SCV002806125 | likely benign | Focal segmental glomerulosclerosis 2 | 2022-01-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001459545 | SCV005214046 | likely benign | not provided | criteria provided, single submitter | not provided |